Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages en Stemming true Single Family Member true

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents

Full Query

IC:A61K36/00 AND EN_ALLTXT:(coronavirus OR coronaviruses OR coronaviridae OR coronavirinae OR orthocoronavirus OR orthocoronaviruses OR orthocoronaviridae OR orthocoronavirinae OR betacoronavirus OR betacoronaviruses OR betacoronaviridae OR betacoronavirinae OR sarbecovirus OR sarbecoviruses OR sarbecoviridae OR sarbecovirinae OR "severe acute respiratory syndrome" OR sars OR "2019 ncov" OR covid)

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.20040009245Methods and apparatus to prevent, treat and cure infections of the human respiratory system by pathogens causing severe acute respiratory syndrome (SARS)
US 15.01.2004
Int.Class A01N 25/00
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
25Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Appl.No 10429077 Applicant Inhalation, Inc. Inventor Vail, III William Banning

Concentrated vapors from botanical essential oils are inhaled to prevent, treat and cure infections of the respiratory pathogens causing Severe Acute Respiratory Syndrome (“SARS”). These vapors are inhaled as a practical method to reduce the risks of infection by the pathogens causing SARS in crowded public places. These vapors are also inhaled as a practical method to reduce the risks of infection by unknown, and unpredictable, respiratory pathogens that may be present in public places. The essential oils have antiseptic properties, are safe to inhale, and include, but are not limited to, the essential oils from Eucalyptus globulus, Melaleuca alternifolia, Eucalyptus citriodora, and Eucalyptus radiata. Convenient hand-held inhaler apparatus are provided for the inhalation of concentrated vapors from the antiseptic essential oils and other substances. The antiseptic essential oils have selected antiviral, antibacterial, and antifungal properties.

2.103156921Application of schisandra chinensis and extracts of schisandra chinensis in resisting severe acute respiratory syndrome (SARS) coronavirus infection
CN 19.06.2013
Int.Class A61K 36/57
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
57Magnoliaceae (Magnolia family)
Appl.No 201110425050.0 Applicant Tianjin International Joint Academy of Biotechnology & Medicine Inventor Rao Zihe
The invention provides the application of schisandra chinensis and extracts of the schisandra chinensis in prevention or treatment of a severe acute respiratory syndrome (SARS) coronavirus infection. When the final concentration of the schisandra chinensis is 500 micrograms per milliliter, the inhibition ratio of isolated SARS coronavirus main protease by 95% ethanol extracts of the schisandra chinensis can reach 92%, and the inhibition ratio of the SARS coronavirus main protease by ethyl acetate extracts of the 95% ethanol extracts of the schisandra chinensis is 89.1%.
3.20080038382Extracts of Scutellaria for the Treatment of Sars
US 14.02.2008
Int.Class A61K 36/185
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
Appl.No 10590287 Applicant ZHONG SHOUMING Inventor Zhong Shouming

The present invention relates to pharmaceutical compositions having antiviral activity against Coronavirus, and more particularly against those viruses responsible for Severe Acute Respiratory Syndrome (SARS). In a preferred embodiment it comprises a total standardized extract of a Scutellariae spp.

4.10729735Method and compostitions for treating coronavirus infection
US 04.08.2020
Int.Class A61K 36/24
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
24Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
Appl.No 16895920 Applicant PHOENIX BIOTECHNOLOGY, INC. Inventor Robert A. Newman

A method of treating viral infection, such as viral infection caused by a virus of the Coronaviridae family, is provided. A composition having at least oleandrin is used to treat viral infection.

5.20060178341Composition comprising soluble glucan oligomer from saccharomyces cerevisiae is2 inhibiting the swine influenza (SIV) and transmissible gastroenteritis coronavirus (tgev)
US 10.08.2006
Int.Class A61K 31/716
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
716Glucans
Appl.No 10561714 Applicant MOON WON KOOK Inventor Moon Won Kook

The present invention relates to the soluble glucan oligomer having a M.W. ranging from 1,000 to 10,000 prepared by treating insoluble beta-glucan isolated the cell wall of yeast variant IS2 with commercially available beta-glucan hydrolyzing enzymes. The soluble glucan oligomer showed potent efficacy on inhibiting activity of influenza virus and transmissible gastroenteritis coronavirus, therefore, it can be used as the therapeutics or health care food for treating and preventing mammal's diseases caused by the infection of influenza virus and transmissible gastroenteritis coronavirus.

6.1020180079136METHOD FOR COMPOSING MATERIAL FOR CONTROLLING AVIAN INFLUENZA, SARS, MERS, AND CORONAVIRUS USING MICROENCAPSULATION TECHNOLOGY-APPLIED NATURAL HERB COMPOSITION
KR 10.07.2018
Int.Class A01N 25/28
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
25Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
26in coated particulate form
28Microcapsules
Appl.No 1020160184595 Applicant GREEN T INDUSTRY. CO., LTD.GREEN T INDUSTRY. CO., LTD. Inventor YOO, HAE HYUNYOO, HAE HYUN
The present invention relates to a method for composing a material for preventing and controlling avian influenza, severe acute respiratory syndrome (SARS), Middle East respiratory syndrome coronavirus (MERS), and coronavirus. More specifically, the present invention relates to a method for composing a prevention/control material which shows practical effects by applying dilution rate of raw materials, a microencapsulation technology, and a composition of natural herbs effective in prevention and control. COPYRIGHT KIPO 2018
7.2010090066ANTI-SARS CORONAVIRUS AGENT AND PRODUCT CONTAINING ANTI-SARS CORONAVIRUS AGENT
JP 22.04.2010
Int.Class A61K 36/18
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
Appl.No 2008262200 Applicant POKKA CORP Inventor FUKUMOTO SHUICHI

PROBLEM TO BE SOLVED: To provide an anti-SARS coronavirus agent having excellent anti-SARS coronavirus action and a product containing the anti-SARS coronavirus agent.

SOLUTION: The anti-SARS coronavirus agent contains, as active components, a guava extract extracted by using an extraction solvent containing at least one kind of solvent selected from water and hydrophilic organic solvents as a main component, and ascorbic acids.

COPYRIGHT: (C)2010,JPO&INPIT

8.WO/2010/041703ANTI-SARS CORONAVIRUS AGENT, AND PRODUCT CONTAINING ANTI-SARS CORONAVIRUS AGENT
WO 15.04.2010
Int.Class A61K 36/18
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
Appl.No PCT/JP2009/067535 Applicant POKKA CORPORATION Inventor FUKUMOTO, Syuichi
Disclosed is an anti-SARS coronavirus agent which comprises, as active ingredients, a guava extract that is extracted from a guava plant with an extraction solvent mainly composed of at least one member selected from water and a hydrophilic organic solvent and an ascorbic acid component.  Preferably, the anti-SARS coronavirus agent further comprises a persimmon extract that is extracted from a persimmon plant with an extraction solvent mainly composed of at least one member selected from water and a hydrophilic organic solvent.  Also disclosed is a product containing an anti-SARS coronavirus agent, which contains the anti-SARS coronavirus agent.
9.111150792Traditional Chinese medicine composition capable of resisting novel coronavirus SARS-Cov-2 as well as preparation method and application of traditional Chinese medicine composition
CN 15.05.2020
Int.Class A61K 36/8966
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
88Liliopsida (monocotyledons)
896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
8966Fritillaria, e.g. checker lily or mission bells
Appl.No 202010165228.1 Applicant JIANGSU HEALTH VOCATIONAL COLLEGE Inventor ZHANG NING
The invention discloses a traditional Chinese medicine composition capable of resisting novel coronavirus SARS-Cov-2 and a preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine composition is prepared from folium isatidis, flos chrysanthemi indici, rhizoma coptidis, cherimoya seeds, agastache rugosus, rhizoma atractylodis, radix bupleuri, calculus bovis factitius, herba houttuyniae, dandelion root, honeysuckles, fructus forsythia, radix scutellariae, rhizoma belamcandae, salvia miltiorrhiza, bulbus fritillariae cirrhosae, saussurea involucrate, radix astragali, cordyceps militaris, radix codonopsis and liquorice. By carrying out screening in a large number of experiments according to pathogenic characteristics of the novel coronavirus SARS-Cov-2 and a viscera screening composition of concurrent injury, researches on in vitro safety and drug efficacy of in vitro novel coronavirus show that the traditional Chinese medicine composition disclosed by the invention has a remarkable inhibition effect to the novel coronavirus SARS-Cov-2. Clinical experimental observation shows that the traditional Chinese medicine composition is capable of remarkably improving pneumonia symptoms concurrent with the novel coronavirus SARS-Cov-2.
10.103156902Application of tripterygium wilfordii and extract thereof in anti-SARS coronavirus infection
CN 19.06.2013
Int.Class A61K 36/37
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
37Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
Appl.No 201110415747.X Applicant Tianjin International Joint Academy of Biotechnology & Medicine Inventor Rao Zihe
The present invention provides applications of tripterygium wilfordii and extracts thereof in prevention or treatment of SARS coronavirus infection. Experiments show that: a 95% ethanol extract of tripterygium wilfordii has an inhibition rate up to 98.8% for SARS main protease at a final concentration of 500 [mu]g/mL; and petroleum ether, ethyl acetate and n-butanol extracts of the 95% ethanol extract respectively have the inhibition rate of 99.3%, 97.2% and 83.8% for the SARS main protease.